INHIBITION OF DENGUE VIRUS BY NOVEL, MODIFIED ANTISENSE OLIGONUCLEOTIDES

被引:31
|
作者
RAVIPRAKASH, K
LIU, K
MATTEUCCI, M
WAGNER, R
RIFFENBURGH, R
CARL, M
机构
[1] GILEAD SCI INC,FOSTER CITY,CA 94404
[2] USN,MED CTR,SAN DIEGO,CA 92134
关键词
D O I
10.1128/JVI.69.1.69-74.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Five different target regions along the length of the dengue virus type 2 genome were compared for inhibition of the virus following intracellular injection of the cognate antisense oligonucleotides and their analogs. Unmodified phosphodiester oligonucleotides as well as the corresponding phosphorothioate oligonucleotides were ineffective in bringing about a significant inhibition of the virus. Novel modified phosphorothioate oligonucleotides in which the C-5 atoms of uridines and cytidines were replaced by propynyl groups caused a significant inhibition of the virus. Antisense oligonucleotide directed against the target region near the translation initiation site of dengue virus RNA was the most effective, followed dy antisense oligonucleotide directed against a target in the 3' untranslated region of the virus RNA. It is suggested that the inhibitory effect of these novel modified oligonucleotides is due to their increased affinity for the target sequences and that they probably function via an RNase H cleavage of the oligonucleotide:RNA heteroduplex.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [41] Antisense oligonucleotides: a novel Frontier in pharmacological strategy
    Collotta, D.
    Bertocchi, I.
    Chiapello, E.
    Collino, M.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] Application of modified antisense oligonucleotides and siRNAs as antiviral drugs
    Wagner, Anke
    Bock, Claus-Thomas
    Fechner, Henry
    Kurreck, Jens
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (13) : 1637 - 1642
  • [43] Antisense oligonucleotides: a novel therapeutic approach.
    Guinot, P
    Temsamani, J
    PATHOLOGIE BIOLOGIE, 1998, 46 (05): : 347 - 354
  • [44] Novel Peptide Conjugates of Modified Oligonucleotides for Inhibition of Bacterial RNase P
    Novopashina, Darya
    Vorobyeva, Mariya
    Nazarov, Anton
    Davydova, Anna
    Danilin, Nikolay
    Koroleva, Lyudmila
    Matveev, Andrey
    Bardasheva, Alevtina
    Tikunova, Nina
    Kupryushkin, Maxim
    Pyshnyi, Dmitrii
    Altman, Sidney
    Venyaminova, Alya
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [45] Inhibition of tumor necrosis factor alpha (TNF alpha) expression and function by modified antisense oligonucleotides.
    Ojwang, JO
    Marshall, HB
    Mustain, S
    Rao, TS
    Chaudhary, N
    Walker, DA
    Akiyama, T
    Hogan, ME
    Revankar, GR
    Peyman, A
    Uhlmann, E
    Rando, R
    BLOOD, 1996, 88 (10) : 2856 - 2856
  • [46] Inhibition of tumor necrosis factor alpha (TNF alpha) expression and function in vitro by modified antisense oligonucleotides
    Ojwang, JO
    Rao, TS
    Marshall, HB
    Mustain, SD
    Chaudhary, N
    Walker, DA
    Peyman, A
    Uhlmann, E
    Revankar, GR
    Rando, RF
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1703 - 1707
  • [47] Antisense oligonucleotides targeted against human immunodeficiency virus
    Friesen, Albert D.
    Biotechnology Advances, 1997, 15 (3-4): : 782 - 783
  • [48] Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides
    Pinskaya, MD
    Brodin, P
    Romanova, EA
    Volkov, EM
    Mouscadet, JF
    Gottikh, MB
    MOLECULAR BIOLOGY, 2000, 34 (06) : 888 - 894
  • [49] Inhibition of the Human Immunodeficiency Virus Type 1 DNA Integration by Modified Oligonucleotides
    M. D. Pinskaya
    P. Brodin
    E. A. Romanova
    E. M. Volkov
    J.-F. Mouscadet
    M. B. Gottikh
    Molecular Biology, 2000, 34 : 888 - 894
  • [50] Novel backbone modified antisense oligonucleotides with improved potency effectively inactivate oncogenic miRNA-21 comparing to phosphorothioate oligonucleotides
    Miroshnichenko, S.
    Patutina, O.
    Burakova, E.
    Chelobanov, B.
    Fokina, A.
    Stetsenko, D.
    Vlassov, V.
    Zenkova, M.
    FEBS OPEN BIO, 2018, 8 : 107 - 107